These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 9706493

  • 1. The role of corticoids, adrenalectomy, phenobarbital and pentobarbital in the promotion of DEN-hepatocarcinogenesis.
    Bouzahzah B, Pavier D, Barbason H.
    In Vivo; 1998; 12(4):411-9. PubMed ID: 9706493
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Correlation between time of partial hepatectomy after a single treatment with diethylnitrosamine and induction of adenosinetriphosphatase-deficient islands in rat liver.
    Ishikawa T, Takayama S, Kitagawa T.
    Cancer Res; 1980 Nov; 40(11):4261-4. PubMed ID: 6451284
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 1alpha,25-Dihydroxyvitamin D(3) inhibits rat liver ultrastructural changes and the development of gamma-glutamyltranspeptidase-positive foci in diethylnitrosamine-initiated and streptozotocin-induced diabetes-promoted hepatocarcinogenesis.
    Saha BK, Bhattacharya R, Chatterjee M.
    Cell Biochem Funct; 2002 Sep; 20(3):195-204. PubMed ID: 12125095
    [Abstract] [Full Text] [Related]

  • 11. Phenobarbital at low dose exerts hormesis in rat hepatocarcinogenesis by reducing oxidative DNA damage, altering cell proliferation, apoptosis and gene expression.
    Kinoshita A, Wanibuchi H, Morimura K, Wei M, Shen J, Imaoka S, Funae Y, Fukushima S.
    Carcinogenesis; 2003 Aug; 24(8):1389-99. PubMed ID: 12807726
    [Abstract] [Full Text] [Related]

  • 12. Reduced hepatocyte proliferation is the basis of retarded liver tumor progression and liver regeneration in mice lacking N-acetylglucosaminyltransferase III.
    Yang X, Tang J, Rogler CE, Stanley P.
    Cancer Res; 2003 Nov 15; 63(22):7753-9. PubMed ID: 14633700
    [Abstract] [Full Text] [Related]

  • 13. Short-term in vivo initiation/promotion bioassay for hepatocarcinogens.
    Ford JO, Pereira MA.
    J Environ Pathol Toxicol; 1980 Nov 15; 4(5-6):39-46. PubMed ID: 6111580
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dissociation of two actions in the positive effect of prior partial hepatectomy on the induction of the hepatocarcinogenic process by diethylnitrosamine.
    Servais P, Fokan D, Galand P.
    Epithelial Cell Biol; 1995 Nov 15; 4(3):113-20. PubMed ID: 8971486
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of mutant frequencies of chemically induced tumors and normal tissues in lambda/cII transgenic mice.
    Mirsalis JC, Shimon JA, Johnson A, Fairchild D, Kanazawa N, Nguyen T, de Boer J, Glickman B, Winegar RA.
    Environ Mol Mutagen; 2005 Nov 15; 45(1):17-35. PubMed ID: 15605353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.